Back to Market Feed

Product Information

MOTPOLY XR 100 MG CAPSULE is a brand product labeled by Aucta Pharmaceuticals, Inc., priced at $21.4301 per EA under NDC 73289006302. Its NADAC has been published 36 times since Dec 17, 2025.

FDA first approved this application on May 4, 2023.

The High Outlier badge above means this manufacturer's average price in the lacosamide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

MOTPOLY XR 100 MG CAPSULE

lacosamide
$21.4301per EA
High Outlier
DEA Schedule CV

Strength

100 mg/1

NDC

73289006302

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

7/1/2026

Active Ingredients

LACOSAMIDE

Approval Type

New Drug (NDA)

FDA Application

NDA216185

FDA Approved

5/4/2023

On Market Since

5/5/2023

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for MOTPOLY XR 100 MG CAPSULE has been published 36 times since Dec 17, 2025, and over the history we have for it it has risen 4.0%. The table below summarizes its recorded NADAC range and movement.

Current price$21.4301 per EA
All-time high$21.4301 (Aug 19, 2026)
All-time low$20.6022 (Dec 17, 2025)
52-week high$21.4301
52-week low$20.6022
Median price$21.2232
Average price$21.1944
Largest weekly change+3.0% (Jan 14, 2026)
Weeks tracked36
Tracking sinceDec 17, 2025

Price History

1W

0.0%

1M

0.0%

3M

+1.0%

6M

+1.0%

1Y

N/A

3Y

N/A

5Y

N/A

All

+4.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the lacosamide market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

TEGRETOL 100 MG/5 ML SUSP
Brand
00078050883•Novartis Pharmaceuticals Corporation
$0.4370
per ML
ZARONTIN 250 MG CAPSULE
Brand
00071023724•Pfizer Inc.
$1.3086
per EA
EPRONTIA 25 MG/ML SOLUTION
Brand
52652900101•Azurity Pharmaceuticals Inc.
$1.5811
per ML
TEGRETOL XR 100 MG TABLET
Brand
00078051005•Novartis Pharmaceuticals Corporation
$1.6273
per EA
CARBATROL ER 200 MG CAPSULE
Brand
54092017212•Takeda Pharmaceuticals America, Inc.
$1.6940
per EA
CARBATROL ER 300 MG CAPSULE
Brand
54092017312•Takeda Pharmaceuticals America, Inc.
$1.6952
per EA
CARBATROL ER 100 MG CAPSULE
Brand
54092017112•Takeda Pharmaceuticals America, Inc.
$1.6996
per EA
KEPPRA 100 MG/ML ORAL SOLN
Brand
50474000148•UCB, Inc.
$1.9186
per ML
TRILEPTAL 300 MG/5 ML SUSP
Brand
00078035752•Novartis Pharmaceuticals Corporation
$1.9303
per ML
DEPAKOTE DR 125 MG SPRINKLE CP
Brand
00074611413•AbbVie Inc.
$1.9659
per EA

Frequently asked questions

What is the NADAC price of MOTPOLY XR 100 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for MOTPOLY XR 100 MG CAPSULE, manufactured by Aucta Pharmaceuticals, Inc., is $21.4301 per EA (NDC 73289006302), effective Aug 19, 2026.

How has the price of MOTPOLY XR 100 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for MOTPOLY XR 100 MG CAPSULE has risen 4.0%. It has been tracked across 36 weekly CMS publications since Dec 17, 2025.

What are the highest and lowest recorded NADAC prices for MOTPOLY XR 100 MG CAPSULE?

Since Dec 17, 2025, the NADAC for MOTPOLY XR 100 MG CAPSULE has ranged from a low of $20.6022 (Dec 17, 2025) to a high of $21.4301 (Aug 19, 2026), with a median of $21.2232 per EA.

Are there cheaper alternatives to MOTPOLY XR 100 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of MOTPOLY XR 100 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures MOTPOLY XR 100 MG CAPSULE?

MOTPOLY XR 100 MG CAPSULE (NDC 73289006302) is labeled by Aucta Pharmaceuticals, Inc., and CMS classifies it as a brand product.